Trovagene Forms European Institute Headed by U Torino Researcher Alberto Bardelli | GenomeWeb

NEW YORK (GenomeWeb) – Trovagene today announced that it is establishing a European subsidiary, Trovagene Research Institute, charged with expanding the capabilities and adoption of the company's Precision Cancer Monitoring platform.

Alberto Bardelli, a University of Torino liquid biopsy researcher, will serve as scientific chair of TRI, Trovagene said. Bardelli has also been a member of the company's scientific advisory board for the past year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.